Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, Chris C. J., Lyall, Helen, Petrie, John R., Gould, Gwyn W., Connell, John M. C., Sattar, Naveed·2001·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jcem.86.6.7580

Cited by (639)

Items 201–300 of 639

  1. Zinc status and polycystic ovarian syndrome: A systematic review and meta-analysis
    Maryam Abedini, Ehsan Ghaedi, Amir Hadi, Hamed Mohammadi, Reza Amani · 2019 · Journal of Trace Elements in Medicine and Biology
  2. Serum C-Reactive Protein (CRP) Levels and Insulin Resistance in Non-Obese Women with Polycystic Ovarian Syndrome, and Effect of Bicalutamide on Hirsutism, CRP Levels and Insulin Resistance
    Mithat Bahçeci, Alpaslan Tuzcu, Naime Canoruç, Yekta Tüzün, Veysel Kıdır, Çetin Aslan · 2004 · Hormone Research in Paediatrics
  3. Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician
    Landon B. Lorenz, Robert A. Wild · 2007 · Clinical Obstetrics & Gynecology
  4. Sex‐specific aspects of venous thromboembolism: What is new and what is next?
    Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter · 2022 · Research and Practice in Thrombosis and Haemostasis
  5. Polycystic Ovary Syndrome Is Associated with an Increased Prevalence of Irritable Bowel Syndrome
    Ruchi Mathur, Ara Ko, Laura J. Hwang, Kimberly Low, Ricardo Azziz, Mark Pimentel · 2009 · Digestive Diseases and Sciences
  6. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome
    Katharina Walch, Christoph Grimm, Robert Zeillinger, Johannes C. Huber, Friedrich Nagele, Lukas Hefler · 2004 · Fertility and Sterility
  7. CRP and IL‐6 concentrations are associated with poor glycemic control despite preserved β‐cell function during the first year after diagnosis of type 1 diabetes
    Anna Schölin, Agneta Siegbahn, Lars Lind, Christian Berne, Göran Sundkvist, Elisabeth Björk, F. Anders Karlsson · 2004 · Diabetes/Metabolism Research and Reviews
  8. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
    Richard S. Legro · 2004 · Human Reproduction
  9. Treatment of PCOS with metformin and other insulin-sensitizing agents
    Emre U Seli, Antoni J. Dulęba · 2004 · Current Diabetes Reports
  10. A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS)
    Raksha Rani, Younis Ahmad Hajam, Rajesh Kumar, Rouf Ahmad Bhat, Seema Rai, Manzoor Ahmad Rather · 2021 · Phytomedicine Plus
  11. Effect of <scp>M</scp>etformin compared with hypocaloric diet on serum <scp>C</scp>‐reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome
    Esfahanian, Fatemeh, Zamani, Mohammad Mahdi, Heshmat, Ramin, Moini nia, Fatemeh · 2013 · Journal of obstetrics and gynaecology research
  12. Serum LBP Is Associated with Insulin Resistance in Women with PCOS
    Qibo Zhu, Zhou Huang, Aipin Zhang, Rufei Gao, Shumin Yang, Changhong Zhao, Yue Wang, Jinbo Hu, Richa Goswami, Lilin Gong et al. · 2016 · PLoS ONE
  13. Interleukin 10 (− 1082 G/A) and (− 819 C/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS)
    Roba Mohamed Talaat, Yasmin A. Mohamed, Ehab H. Mohamad, Marwa Elsharkawy, Adel A. Guirgis · 2016 · Meta Gene
  14. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women
    Esra Nur Tola, Serenat Eriş Yalçın, Nadiye Dugan · 2017 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  15. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome
    Rulin Deniz, Şeyda Yavuzkır, Kader Uğur, Döndü Ülker Üstebay, Yakup Baykuş, Sefer Üstebay, Süleyman Aydın · 2020 · Journal of Obstetrics and Gynaecology
  16. Linoleic acid induces human ovarian granulosa cell inflammation and apoptosis through the ER-FOXO1-ROS-NFκB pathway
    Wenying Zhang, Fuju Wu · 2024 · Scientific Reports
  17. Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics
    Vineet Singh, Kanika Mahra, Da-Ryung Jung, Jae‐Ho Shin · 2024 · Probiotics and Antimicrobial Proteins
  18. Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
    Małgorzata Jacewicz‐Święcka, Irina Kowalska · 2018 · Diabetes/Metabolism Research and Reviews
  19. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case–control study of women from Bahraini medical clinics
    Shirin Kalyan, Azita Goshtesabi, Sameh Sarray, Angela Joannou, Wassim Youssef Almawi · 2018 · BMJ Open
  20. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena
    Mariangela Rondanelli, Simone Perna, Milena Anna Faliva, Francesca Monteferrario, Erica Repaci, Francesca Allieri · 2014 · Archives of Gynecology and Obstetrics
  21. Role of Haptoglobin in Polycystic Ovary Syndrome (PCOS), Obesity and Disorders of Glucose Tolerance in Premenopausal Women
    Francisco Álvarez‐Blasco, María Ángeles Martínez-García, Manuel Luque‐Ramírez, Naiara Parraza, José L. San Millán, Héctor Francisco Escobar-Morreale · 2009 · PLoS ONE
  22. Higher carotid‐radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes
    O. D. McEleavy, Roland W. McCallum, John R. Petrie, MICHAEL P. SMALL, J. M. C. Connell, Naveed A. Sattar, Stephen J. Cleland · 2004 · Diabetic Medicine
  23. Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial
    Haiyan Chen, Xiaohui Lei, Zhuoran Yang, Yuxin Xu, Dongfang Liu, Cong Wang, Hu Du · 2025 · Reproductive Biology and Endocrinology
  24. Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS
    Wencui Wang, Shenglin Wang, Shan Tan, Meiqin Wen, Yanzhi Qian, Xiaofang Zeng, Yanlei Guo, Chao Yu · 2015 · Clinica Chimica Acta
  25. Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity
    Htet, Thaw D., Teede, Helena J., de Courten, Barbora, Loxton, Deborah, Real, Francisco G., Moran, Lisa J., Joham, Anju E. · 2017 · European Respiratory Journal
  26. Effect of Non‐Surgical Periodontal Therapy Along With Myo‐Inositol on High‐Sensitivity C‐Reactive Protein and Insulin Resistance in Women With Polycystic Ovary Syndrome and Chronic Periodontitis: A Randomized Controlled Trial
    Deepti, Shikha Tewari, Satish Chander Narula, Savita Rani Singhal, Rajinder Kumar Sharma · 2017 · Journal of Periodontology
  27. Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
    Saqib Hassan, Marika Kaakinen, Harmen H. M. Draisma, Liudmila Zudina, Mohd Ashraf Ganie, Aafia Rashid, Zhanna Balkhiyarova, George Seghal Kiran, Paris Vogazianos, Christos Shammas et al. · 2022 · Genes
  28. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
    Kousta, Eleni, Tolis, George, Franks, Stephen · 2005 · HORMONES
  29. Polycystic ovary syndrome and periodontal disease: Underlying links- A review
    Sri Chandana Tanguturi, Sreenivas Nagarakanti · 2018 · Indian Journal of Endocrinology and Metabolism
  30. Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
    Chaitra Shetty, Syed Muhammad Hannan Ali Rizvi, Joudi Sharaf, Kerry-Ann D Williams, Maha Tariq, Maitri V Acharekar, Sara Elena Guerrero Saldivia, Sumedha Unnikrishnan, Yeny Y Chavarria, Adebisi O Akindele et al. · 2023 · Cureus
  31. Is there any relationship between cardiovascular risk markers and young women with diminished ovarian reserve?
    Fatma Ferda Verit, Seda Keskin, Beyhan Ömer, Şener Yalçınkaya, Mehmet Nafi Sakar · 2014 · Gynecological Endocrinology
  32. Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters
    Barış Önder Pamuk, Ayşe Nur Torun, Mustafa Kulaksızoğlu, Derun Taner Ertuğrul, Özgür Çiftçi, Sevsen Kulaksızoğlu, Erkan Yıldırım, Nilgün Güvener Demirağ · 2008 · Fertility and Sterility
  33. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study
    Lenora Maria Camarate Silveira Martins Leão, Mônica P.C. Duarte, Dalva Margareth B Silva, Paulo Roberto Valle Bahia, Cláudia Medina Coeli, Maria Lúcia Fleiuss Farias · 2005 · European Journal of Endocrinology
  34. Effect of bee venom on IL-6, COX-2 and VEGF levels in polycystic ovarian syndrome induced in Wistar rats by estradiol valerate
    Latifeh Karimzadeh, Mohammad Nabiuni, Homa Mohseni Kouchesfahani, Hamed Adham, Amir Bagheri, Azar Sheikholeslami · 2013 · The Journal of venomous animals and toxins including tropical diseases
  35. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
    Karbek, Basak, Ozbek, Mustafa, Karakose, Melia, Topaloglu, Oya, Bozkurt, Nujen, Cakır, Evrim, Aslan, Muyesser, Delibasi, Tuncay · 2014 · Journal of Ovarian Research
  36. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
    Mohd Ashraf Ganie, Saqib Hassan, Sobia Nisar, Nasir Shamas, Aafia Rashid, Ishfaq Ahmed, Syed Douhat, Syed Mudassar, Vicar M Jan, Fouzia Rashid · 2014 · Gynecological Endocrinology
  37. Effects of the Insulin Sensitizer Pioglitazone on Menstrual Irregularity, Insulin Resistance and Hyperandrogenism in Young Women with Polycystic Ovary Syndrome
    Gaspare Stabile, Irene Borrielli, Alfredo Carducci Artenisio, Lucia Maria Bruno, Salvatore Benvenga, Loretta Giunta, Antonio La Marca, Annibale Volpe, Alfonsa Pizzo · 2014 · Journal of Pediatric and Adolescent Gynecology
  38. Stress in Women
    Evanthia Diamanti‐Kandarakis, Frangiskos Economou · 2006 · Annals of the New York Academy of Sciences
  39. Study on Chronic Low-Grade Inflammation and Influential Factors of Polycystic Ovary Syndrome
    Xiangyan Ruan, Yujie Dai · 2009 · Medical Principles and Practice
  40. Polycystic ovary syndrome in post-menopausal women—marker of the metabolic syndrome
    Elena Margolin, Taiba Zornitzki, Gideon Kopernik, Sofy Kogan, Ami Schattner, Hilla Knobler · 2004 · Maturitas
  41. Effects of intestinal flora on polycystic ovary syndrome
    Jiayue Liu, Ying Liu, Xiaoliang Li · 2023 · Frontiers in Endocrinology
  42. Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
    Talip Gul · 2015 · Medical Science Monitor
  43. Recent advances in mammalian reproductive biology
    Lu Wen, Qiang Liu, Jing-Jing Xu, Xixi Liu, Chao-Yi Shi, Zuwei Yang, Yili Zhang, Hong Xu, Jiang Liu, Hui Yang et al. · 2019 · Science China Life Sciences
  44. γ-Linolenic acid ameliorates DHEA induced pro-inflammatory response in polycystic ovary syndrome via PPAR-γ signaling in rats
    Yogamaya Divakar Prabhu, Abilash Valsala Gopalakrishnan · 2020 · Reproductive Biology
  45. The Content of Minerals in the PCOS Group and the Correlation with the Parameters of Metabolism
    Kamila Pokorska‐Niewiada, Agnieszka Brodowska, Małgorzata Szczuko · 2021 · Nutrients
  46. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome
    Fatma Ferda Verit · 2009 · Archives of Gynecology and Obstetrics
  47. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
    Aida Santaolalla, Sam Sollie, Ali Rislan, Debra Hannah Josephs, Niklas Hammar, Göran Walldius, Ingmar Jungner, Hans Garmo, Sophia N. Karagiannis, Mieke Van Hemelrijck · 2021 · BMC Immunology
  48. Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study
    Francesco Giallauria, Francesco Orio, Gaetano Lombardi, Annamaria Colao, Carlo Vigorito, Maria Tafuri, Stefano Palomba · 2009 · Journal of Ovarian Research
  49. Waist circumference in relation to outcomes of infertility treatment with assisted reproductive technologies
    Ming‐Chieh Li, Lidia Mínguez‐Alarcón, Mariel Arvizu, Yu‐Han Chiu, Jennifer B. Ford, Paige L. Williams, Jill Attaman, Russ B. Hauser, Jorge E. Chavarro · 2019 · American Journal of Obstetrics and Gynecology
  50. The role of alpha lipoic acid in female and male infertility: a systematic review
    Chiara Di Tucci, Giulia Galati, Giulia Mattei, Valentina Bonanni, Oriana Capri, Renzo D'Amelio, Ludovico Muzii, Pierluigi Benedetti Panici · 2020 · Gynecological Endocrinology
  51. Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
    Helen Diane Mason, Annamaria Colao, Ulrike Blume‐Peytavi, Suman Rice, Asjid Qureshi, Laura Jane Pellatt, Francesco Orio, Stephen Lawrence Atkin · 2008 · Clinical Endocrinology
  52. Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation
    Joseph S. Marino, Jeffrey Iler, Abigail R. Dowling, Streamson C. Chua, Jens C. Brüning, Roberto Coppari, Jennifer Wootton Hill · 2012 · PLoS ONE
  53. Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
    Cheang, Kai I., Nestler, John E., Futterweit, Walter · 2008 · Endocrine Practice
  54. Correlation of platelet to lymphocyte and neutrophil to lymphocyte ratio with hormonal and metabolic parameters in women with PCOS
    Vasilios Pergialiotis, Eftihios Trakakis, Christos Parthenis, Erifili E. Hatziagelaki, Charalampos G. Chrelias, Nikolaos Thomakos, Nikolaos E. Papantoniou · 2018 · Hormone Molecular Biology and Clinical Investigation
  55. Pyroptosis and inflammasomes in obstetrical and gynecological diseases
    Shu-Yue Yu, Xue‐Lian Li · 2021 · Gynecological Endocrinology
  56. The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome
    Merve Esra Çıtar Dazıroğlu, Nilüfer Acar Tek · 2023 · Current Nutrition Reports
  57. Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population
    Hui Yuan Gao, Jie Meng, Mengjing Xu, Shun Zhang, Ghose Bishwajit, Jun Liu, Ping Yao, Hong Yan, Di Wang, Liegang Liu · 2013 · PLoS ONE
  58. HMG-CoA Reductase Inhibitors
    Pinar H. Kodaman, Antoni J. Dulęba · 2008 · Drugs
  59. Suprabasin—A Review
    Miroslav Přibyl, Zdeněk Hodný, Iva Kubíková · 2021 · Genes
  60. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease: review of the evidence
    Evelyn O. Talbott, Jeanne V. Zborowski, M. Y. Boudreaux · 2004 · International Congress Series
  61. The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients
    M. Erdogan, M. Karadeniz, Afig Berdelı, Gulinnaz E Alper, Osman Çağlayan, Canan Yılmaz · 2008 · Journal of Endocrinological Investigation
  62. Síndrome dos ovários policísticos, síndrome metabólica, risco cardiovascular e o papel dos agentes sensibilizadores da insulina
    Regina do Carmo Silva, Dolores Pardini, Claudio Elias Kater · 2006 · Arquivos Brasileiros de Endocrinologia & Metabologia
  63. Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study
    Katrina Rautio, Juha S. Tapanainen, Aimo Ruokonen, Laure C. Morin-Papunen · 2006 · Fertility and Sterility
  64. Polycystic Ovary Syndrome
    Naveed A. Sattar, Richard Fleming · 2005
  65. The role of the autonomic nervous system in polycystic ovary syndrome
    Yue Yu, Tong Chen, Zheng Zheng, Fan Jia, Yan Liao, Yuehan Ren, Xinmin Liu, Ying Liu · 2024 · Frontiers in Endocrinology
  66. C-reactive protein and ART outcomes: a systematic review
    Sophie Brouillet, Guilaine Boursier, Margaux Anav, Bertille Du Boulet De La Boissière, Anna Gala, Alice Ferrières-Hoa, Isabelle Touitou, S. Hamamah · 2020 · Human Reproduction Update
  67. The immune system’s role in PCOS
    Maryam Shamsi, Ali Ghazavi, Amir Mohammad Saeedifar, Ghasem Mosayebi, Sana Khajehpour, Ali Ganji · 2022 · Molecular Biology Reports
  68. Hormonal factors and respiratory health in women – a review
    Francisco Gómez Real, Cecilie Svanes, Ferenc Macsali, Ernst Reidar Omenaas · 2008 · The Clinical Respiratory Journal
  69. Cardiovascular risk factors in polycystic ovary syndrome
    Abdullah Karaer, Sabri Cavkaytar, İsmail Mert, U. Buyukkagnici, Sertaç Batıoğlu · 2010 · Journal of Obstetrics and Gynaecology
  70. CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome
    Giampaolo Niccoli, Rosanna Apa, Antonio Lanzone, Giovanna Liuzzo, Cristina Spaziani, Francesca Sagnella, Nicola Cosentino, F. Moro, Daniela Martínez, Andrea Morciano et al. · 2011 · Fertility and Sterility
  71. Evaluation of homocysteine levels in patients with polycystic ovarian syndrome.
    Shadab Salehpour, Ozra Manzor-al-ajdad, Elham Neisani Samani, Alireza Abadi · 2011 · PubMed Central
  72. Discontinuous low-dose flutamide–metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-α and the neutrophil/lymphocyte ratio
    Lourdes Ibáñez, Carme Valls, Francis de Zegher · 2005 · Human Reproduction
  73. Polycystic Ovary Syndrome in Adolescence
    Elizabeth E. Baumann, Robert L. Rosenfield · 2002 · The Endocrinologist
  74. Acute phase proteins: C-reactive protein and fibrinogen in young women with polycystic ovary syndrome
    Maja Nasiek, Beata Kos‐Kudła, Zofia Ostrowska, Bogdan Marek, Marek Jerzy Kudla, Lucyna Siemińśka, Dariusz Kajdaniuk, Wanda Fołtyn, Anna Zemczak · 2006 · Pathophysiology
  75. The Potential Relationship Between Different Human Female Reproductive Disorders and Sperm Quality in Female Genital Tract
    Forough Mahdavinezhad, Roghaye Gharaei, Ahmad Reza Farmani, Farideh Hashemi, Mahsa Kouhestani, Fardin Amidi · 2021 · Reproductive Sciences
  76. Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
    Jin Yu, Yulai Zhou, Jie Ding, Danying Zhang, Chaoqin Yu, Hefeng Huang · 2023 · Frontiers in Endocrinology
  77. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sadık Şahin, Mustafa Eroğlu, S Selcuk, Lale Susan Turkgeldi, Şükran Kozalı, S Davutoğlu, Murat Muhçu · 2014 · PubMed
  78. Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome
    Mert Küçük, Sündüz Özlem Altınkaya, Sümeyra Nergiz, Selda Demırcan Sezer, Hasan Yüksel, İhsan Bağlı, Gülserap Yıldız · 2014 · Gynecological Endocrinology
  79. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test
    Ismail Cem Yildir, Faruk Kutlutürk, Türker Taşlıyurt, Berna Yelken, Berat Acu, Murat Beyhan, Ünal Erkorkmaz, Abdülkerim Yılmaz · 2012 · Gynecological Endocrinology
  80. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies
    Belén Peral, Emilio Camafeita, José Manuel Fernández‐Real, Juan Antonio López · 2009 · Expert Review of Proteomics
  81. Effects of Drospirenone–Ethinylestradiol and/or Metformin on CD4+CD28null T Lymphocytes Frequency in Women With Hyperinsulinemia Having Polycystic Ovary Syndrome: A Randomized Clinical Trial
    F. Moro, Andrea Morciano, Anna Tropea, Francesca Sagnella, Carola Palla, Elisa Scarinci, Andrea Ciardulli, Daniela Martínez, Alessandra Familiari, Giovanna Liuzzo et al. · 2013 · Reproductive Sciences
  82. New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties
    Qing Xia, Wenjing Wang, Zijie Liu, Jiaying Xiao, Cong Qiao, Yu Zhao, Bowen Li, Yuanli Liu, Yahui Peng, Xinyu Yang et al. · 2022 · European Journal of Pharmacology
  83. Health-promoting and disease-preventive potential of Trianthema portulacastrum Linn. (Gadabani)—An Indian medicinal and dietary plant
    Jason Yamaki, Kalyan C. Nagulapalli Venkata, Animesh Mandal, Piyali Bhattacharyya, Anupam Bishayee · 2016 · Journal of Chinese Integrative Medicine
  84. Inflammation and Its Relationship to Insulin Resistance, Type 2 Diabetes Mellitus, and Endothelial Dysfunction
    Joshua I. Barzilaym, Eric S. Freedland · 2003 · Metabolic Syndrome and Related Disorders
  85. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive‐aged women with polycystic ovary syndrome: A systematic review and meta‐analysis of 45 observational studies
    Maryam Kazemi, Roger A. Pierson, Stephen Anthony Parry, Mojtaba Kaviani, Philip David Chilibeck · 2021 · Obesity Reviews
  86. Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome
    Shike Zhang, Hui He, Yu Wang, Xiao Wang, Xiaofang Liu · 2023 · Scientific Reports
  87. Polymorphism of the interleukin‐10 gene in polycystic ovary syndrome
    M. Karadeniz, M. Erdogan, Ayhan Zengi, Sadık Tamsel, Afig Berdelı, Füsun Saygılı, C. Yilmaz · 2008 · International Journal of Immunogenetics
  88. Expression Levels of Vascular Cell Adhesion Molecule-1 in Young and Nonobese Women with Polycystic Ovary Syndrome
    Kok‐Min Seow, Chi‐Chang Juan, Peng‐Hui Wang, Low‐Tone Ho, Jiann‐Loung Hwang · 2012 · Gynecologic and Obstetric Investigation
  89. The effect of ethinyl estradiol–cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome
    Ozgur Baris Gul, Aslı Somunkiran, Oğuz Yücel, Fuat Demirci, İsmail Özdemir · 2007 · Archives of Gynecology and Obstetrics
  90. Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: A new etiologic factor in polycystic ovary syndrome?
    Laure C. Morin-Papunen, Antoni J. Dulęba, Aini H. Bloigu, Marjo‐Riitta Järvelin, Pekka Saikku, Anneli M. Pouta · 2009 · Fertility and Sterility
  91. Polycystic Ovary Syndrome and Chronic Inflammation: Pharmacotherapeutic Implications
    Susan M. Sirmans, Emily Weidman-Evans, Victoria Everton, Daniel Thompson · 2012 · Annals of Pharmacotherapy
  92. The relationship of the interleukin‐6 −174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients
    Mehmet Erdoğan, M. Karadeniz, Afig Berdelı, Sadık Tamsel, Canan Yılmaz · 2009 · International Journal of Immunogenetics
  93. Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGfs)/IGF-binding proteins (IGFBPs).
    Hsin‐Shih Wang, Tzu‐Hao Wang · 2003 · PubMed
  94. Interleukin-22 promotes proliferation and reverses LPS-induced apoptosis and steroidogenesis attenuation in human ovarian granulosa cells: implications for polycystic ovary syndrome pathogenesis
    Linhong Liu, Xu Li, Ying Chen, Yi-Zhe Li, Zhen Liu, Yu Duan · 2023 · Journal of Maternal-Fetal & Neonatal Medicine
  95. PCOS: update and diagnostic approach
    Oranite Goldrat, Anne Delbaere · 2018 · Clinical Biochemistry
  96. The plasma level and gene expression of resistin in polycystic ovary syndrome
    Jing Zhang, Lingling Zhou, Liulin Tang, Liangzhi Xu · 2011 · Gynecological Endocrinology
  97. High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome
    Ji Won Kim, Ji Eun Han, You Shin Kim, Hyung Jae Won, Tae Ki Yoon, Woo Sik Lee · 2011 · Gynecological Endocrinology
  98. A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells
    Yufuko Kai, Yasushi Kawano, Hanae Yamamoto, Hisashi Narahara · 2015 · Reproductive Biology and Endocrinology
  99. Pioglitazone treatment decreases follicular fluid levels of tumor necrosis factor-α and interleukin-6 in patients with polycystic ovary syndrome
    Chung‐Hoon Kim, Jun‐Woo Ahn, Rae-Mi You, Sung-Hoon Kim, Hee‐Dong Chae, Byung‐Moon Kang · 2011 · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine
  100. Premature Adrenarche Leads to Polycystic Ovary Syndrome?
    Eleni Κousta · 2006 · Annals of the New York Academy of Sciences